Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
暂无分享,去创建一个
N. Day | N. White | T. Hien | P. Singhasivanon | W. Hanpithakpong | N. Lindegårdh | N. Day | J. Farrar | A. Phakdeeraj | T. T. Hien | N. Lindegårdh | N. White | N. J. White | Warunee Hanpithakpong
[1] A. Deelder,et al. Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. , 2008, Analytical chemistry.
[2] N. Day,et al. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] Vinod P. Shah,et al. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007, The AAPS Journal.
[4] James L. Little,et al. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] C. Macken,et al. Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses , 2005, Antiviral therapy.
[6] F. Hayden,et al. Efficacy and Tolerability of the Oral Neuraminidase Inhibitor Peramivir in Experimental Human Influenza: Randomized, Controlled Trials for Prophylaxis and Treatment , 2005, Antiviral therapy.
[7] J. Gebler,et al. A rapid sample preparation method for mass spectrometric characterization of N-linked glycans. , 2005, Rapid communications in mass spectrometry : RCM.
[8] N. Day,et al. Development and Validation of a Solid-Phase Extraction-Liquid Chromatographic Method for Determination of Amoxicillin in Plasma , 2005, Therapeutic drug monitoring.
[9] Pooran Chand,et al. Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo. , 2005, Bioorganic & medicinal chemistry.
[10] Fabio Garofolo,et al. Bioanalytical Method Validation , 2004 .
[11] S. Liao,et al. Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers , 2002, AAPS PharmSci.
[12] J. King,et al. New sample preparation technique for the determination of avoparcin in pressurized hot water extracts from kidney samples. , 2002, Journal of chromatography. A.
[13] R. Webster,et al. Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses , 2001, Antimicrobial Agents and Chemotherapy.
[14] D. Smee,et al. Pharmacodynamic Evaluation of RWJ-270201, a Novel Neuraminidase Inhibitor, in a Lethal Murine Model of Influenza Predicts Efficacy for Once-Daily Dosing , 2001, Antimicrobial Agents and Chemotherapy.
[15] D. Smee,et al. In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201 , 2001, Antimicrobial Agents and Chemotherapy.
[16] S. Bantia,et al. Anti-influenza virus activity of peramivir in mice with single intramuscular injection. , 2006, Antiviral research.